These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
752 related articles for article (PubMed ID: 35100984)
1. Bacterial co-infections in community-acquired pneumonia caused by SARS-CoV-2, influenza virus and respiratory syncytial virus. Hedberg P; Johansson N; Ternhag A; Abdel-Halim L; Hedlund J; Nauclér P BMC Infect Dis; 2022 Jan; 22(1):108. PubMed ID: 35100984 [TBL] [Abstract][Full Text] [Related]
2. The role of respiratory co-infection with influenza or respiratory syncytial virus in the clinical severity of COVID-19 patients: A systematic review and meta-analysis. Cong B; Deng S; Wang X; Li Y J Glob Health; 2022 Sep; 12():05040. PubMed ID: 36112521 [TBL] [Abstract][Full Text] [Related]
3. Clinical phenotypes and outcomes of SARS-CoV-2, influenza, RSV and seven other respiratory viruses: a retrospective study using complete hospital data. Hedberg P; Karlsson Valik J; van der Werff S; Tanushi H; Requena Mendez A; Granath F; Bell M; Mårtensson J; Dyrdak R; Hertting O; Färnert A; Ternhag A; Naucler P Thorax; 2022 Feb; 77(2):154-163. PubMed ID: 34226206 [TBL] [Abstract][Full Text] [Related]
4. Characteristics and outcomes of patients hospitalized for infection with influenza, SARS-CoV-2 or respiratory syncytial virus in the season 2022/2023 in a large German primary care centre. Quarg C; Jörres RA; Engelhardt S; Alter P; Budweiser S Eur J Med Res; 2023 Dec; 28(1):568. PubMed ID: 38053110 [TBL] [Abstract][Full Text] [Related]
5. Severity of respiratory syncytial virus compared with SARS-CoV-2 and influenza among hospitalised adults ≥65 years. Vega-Piris L; Carretero SG; Mayordomo JL; Zarzuelo MBR; Río VÁ; García VG; Vázquez MG; Rodríguez MDCG; Basile L; González-Coviella NL; Boada MIB; Pérez-Martínez O; Azevedo AL; Rubio CQ; Duran JG; Ibáñez AF; Rivera MVG; Marín VR; Castrillejo D; Raymundo LJV; Larrauri A; Monge S; J Infect; 2024 Nov; 89(5):106292. PubMed ID: 39341402 [TBL] [Abstract][Full Text] [Related]
6. Bacterial and fungal coinfection among hospitalized patients with COVID-19: a retrospective cohort study in a UK secondary-care setting. Hughes S; Troise O; Donaldson H; Mughal N; Moore LSP Clin Microbiol Infect; 2020 Oct; 26(10):1395-1399. PubMed ID: 32603803 [TBL] [Abstract][Full Text] [Related]
7. Burden of primary influenza and respiratory syncytial virus pneumonia in hospitalised adults: insights from a 2-year multi-centre cohort study (2017-2018). Boattini M; Charrier L; Almeida A; Christaki E; Moreira Marques T; Tosatto V; Bianco G; Iannaccone M; Tsiolakkis G; Karagiannis C; Maikanti P; Cruz L; Antão D; Moreira MI; Cavallo R; Costa C Intern Med J; 2023 Mar; 53(3):404-408. PubMed ID: 34633761 [TBL] [Abstract][Full Text] [Related]
8. Focusing on severe infections with the respiratory syncytial virus (RSV) in adults: Risk factors, symptomatology and clinical course compared to influenza A / B and the original SARS-CoV-2 strain. Ambrosch A; Luber D; Klawonn F; Kabesch M J Clin Virol; 2023 Apr; 161():105399. PubMed ID: 36863135 [TBL] [Abstract][Full Text] [Related]
9. Comparative incidence of early and late bloodstream and respiratory tract co-infection in patients admitted to ICU with COVID-19 pneumonia versus Influenza A or B pneumonia versus no viral pneumonia: wales multicentre ICU cohort study. Pandey M; May A; Tan L; Hughes H; Jones JP; Harrison W; Bradburn S; Tyrrel S; Muthuswamy B; Berry N; Pugh R; Sutton D; Campbell A; Morgan M Crit Care; 2022 Jun; 26(1):158. PubMed ID: 35655224 [TBL] [Abstract][Full Text] [Related]
10. Outcomes of SARS-CoV-2 Omicron Variant Infections Compared With Seasonal Influenza and Respiratory Syncytial Virus Infections in Adults Attending the Emergency Department: A Multicenter Cohort Study. Hedberg P; Karlsson Valik J; Abdel-Halim L; Alfvén T; Nauclér P Clin Infect Dis; 2024 Apr; 78(4):900-907. PubMed ID: 37883521 [TBL] [Abstract][Full Text] [Related]
11. Infection and co-infection patterns of community-acquired pneumonia in patients of different ages in China from 2009 to 2020: a national surveillance study. Liu YN; Zhang YF; Xu Q; Qiu Y; Lu QB; Wang T; Zhang XA; Lin SH; Lv CL; Jiang BG; Li H; Li ZJ; Gao GF; Yang WZ; Hay SI; Wang LP; Fang LQ; Liu W; Lancet Microbe; 2023 May; 4(5):e330-e339. PubMed ID: 37001538 [TBL] [Abstract][Full Text] [Related]
12. Community-acquired bacterial co-infection predicts severity and mortality in influenza-associated pneumonia admitted patients. Teng F; Liu X; Guo SB; Li Z; Ji WQ; Zhang F; Zhu XM J Infect Chemother; 2019 Feb; 25(2):129-136. PubMed ID: 30448361 [TBL] [Abstract][Full Text] [Related]
13. Comparison between the Viral Illness Caused by SARS-CoV-2, Influenza Virus, Respiratory Syncytial Virus and Other Respiratory Viruses in Pediatrics. Brigadoi G; Demarin GC; Boracchini R; Pierantoni L; Rossin S; Barbieri E; Tirelli F; Cantarutti A; Tempo G; Giaquinto C; Lanari M; Da Dalt L; Donà D Viruses; 2024 Jan; 16(2):. PubMed ID: 38399975 [TBL] [Abstract][Full Text] [Related]
14. Tracking severe acute respiratory syndrome coronavirus 2 transmission and co-infection with other acute respiratory pathogens using a sentinel surveillance system in Rift Valley, Kenya. Ruttoh VK; Symekher SL; Majanja JM; Opanda SM; Chitechi EW; Wadegu M; Tonui R; Rotich PK; Nyandwaro TT; Mwangi AW; Mwangi IN; Oira RM; Musimbi AG; Nzou SM Influenza Other Respir Viruses; 2023 Nov; 17(11):e13227. PubMed ID: 38019696 [TBL] [Abstract][Full Text] [Related]
15. Assessing respiratory viral exclusion and affinity interactions through co-infection incidence in a pediatric population during the 2022 resurgence of influenza and RSV. Weidmann MD; Green DA; Berry GJ; Wu F Front Cell Infect Microbiol; 2023; 13():1208235. PubMed ID: 37389220 [TBL] [Abstract][Full Text] [Related]
16. Severity of influenza virus and respiratory syncytial virus coinfections in hospitalized adult patients. Zhang Y; Zhao J; Zou X; Fan Y; Xiong Z; Li B; Wang C; Li H; Han J; Liu X; Xia Y; Lu B; Cao B; J Clin Virol; 2020 Dec; 133():104685. PubMed ID: 33220548 [TBL] [Abstract][Full Text] [Related]
17. Comparative analysis of mortality in patients admitted with an infection with influenza A/B virus, respiratory syncytial virus, rhinovirus, metapneumovirus or SARS-CoV-2. Boon H; Meinders AJ; van Hannen EJ; Tersmette M; Schaftenaar E Influenza Other Respir Viruses; 2024 Jan; 18(1):e13237. PubMed ID: 38249443 [TBL] [Abstract][Full Text] [Related]
18. Comparative analysis of CRP as a biomarker of the inflammatory response intensity among common viral infections affecting the lungs: COVID-19 versus influenza A, influenza B and respiratory syncytial virus. Levinson T; Wasserman A; Shenhar-Tsarfaty S; Halutz O; Shapira I; Zeltser D; Rogowski O; Berliner S; Ziv-Baran T Clin Exp Med; 2023 Dec; 23(8):5307-5313. PubMed ID: 37640989 [TBL] [Abstract][Full Text] [Related]
19. Predictors of all-cause mortality among patients hospitalized with influenza, respiratory syncytial virus, or SARS-CoV-2. Hamilton MA; Liu Y; Calzavara A; Sundaram ME; Djebli M; Darvin D; Baral S; Kustra R; Kwong JC; Mishra S Influenza Other Respir Viruses; 2022 Nov; 16(6):1072-1081. PubMed ID: 35611399 [TBL] [Abstract][Full Text] [Related]
20. Burden of Influenza and Respiratory Syncytial Viruses in Suspected COVID-19 Patients: A Cross-Sectional and Meta-Analysis Study. Costa VGD; Gomes AJC; Bittar C; Geraldini DB; Previdelli da Conceição PJ; Cabral ÁS; Carvalho T; Biselli JM; Provazzi PJS; Campos GRF; Sanches PRDS; Costa PI; Nogueira ML; Araujo JP; Spilki FR; Calmon MF; Rahal P Viruses; 2023 Mar; 15(3):. PubMed ID: 36992374 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]